Concepedia

María I. Albarrán

MI

14

Publications

397

Citations

12

H-Index

2005

Active since

Affiliations

Spanish National Cancer Research Centre(Current)

María I. Albarrán is an author at Spanish National Cancer Research Centre specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

2005–2021

14

Publications

14

Chemical Interrogation of FOXO3a Nuclear Translocation Identifies Potent and Selective Inhibitors of Phosphoinositide 3-Kinases

Wolfgang Link, Julen Oyarzábal, Beatriz G. Serelde et al. · Journal of Biological Chemistry · 2009 · 79 citations · Full text

Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies

Rodrigo A. Toledo, Elena Garralda, Maria Mitsi et al. · Clinical Cancer Research · 2018 · 47 citations

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors

Joaquı́n Pastor, Julen Oyarzábal, Gustavo Saluste et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 44 citations · Full text

, , +9

Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors

Sonia Martı́nez, Sonsoles Rodríguez-Arístegui, Cristina Gómez de la Oliva et al. · European Journal of Medicinal Chemistry · 2019 · 37 citations · Full text

, , +6

Discovery of Mitogen-Activated Protein Kinase-Interacting Kinase 1 Inhibitors by a Comprehensive Fragment-Oriented Virtual Screening Approach

Julen Oyarzábal, Natasha Zarich, María I. Albarrán et al. · Journal of Medicinal Chemistry · 2010 · 35 citations · Full text

Rows per page

1–5 of 14